Head and Neck Cutaneous Squamous Cell Carcinoma

• CLINICAL_TRIALS trial_result · 2026-04-27
  Clinical Trial Update: Testing the Addition of an Immunotherapy Drug, Cemiplimab (REGN2810), Plus Surgery to the Usual Surgery Alone for Treating Advanced Skin Cancer [Phase 3]

  Phase 3 trial evaluating cemiplimab added to surgery for advanced eyelid/skin squamous cell carcinoma; currently recruiting.

• CLINICAL_TRIALS trial_result · 2026-04-24
  Clinical Trial Update: Testing the Addition of an Immunotherapy Drug, Cemiplimab (REGN2810), Plus Surgery to the Usual Surgery Alone for Treating Advanced Skin Cancer [Phase 3]

  A Phase 3 trial is evaluating adding cemiplimab to surgery versus surgery alone for advanced eyelid and other cutaneous squamous cell carcin…

• CLINICAL_TRIALS research · 2026-04-13
  Clinical Trial Update: Testing the Use of Investigational Drugs Atezolizumab and/or Bevacizumab With or Without Standard Chemotherapy in the Second-Line Treatment of Advanced-Stage Head and Neck Cancers [Phase 2, Phase 3]

  This clinical trial update describes a Phase 2/Phase 3 study evaluating atezolizumab and/or bevacizumab with or without standard chemotherap…

• CLINICAL_TRIALS other · 2026-04-03
  Clinical Trial Update: Comparing Cisplatin Every Three Weeks to Cisplatin Weekly When Combined With Radiation for Patients With Advanced Head and Neck Cancer [Phase 2, Phase 3]

  NRG Oncology reports suspension of a phase 2/3 trial comparing cisplatin dosing every three weeks versus weekly when given with radiation fo…

• CLINICAL_TRIALS research · 2026-02-25
  Clinical Trial Update: Cemiplimab in Treating Patients With Recurrent and Resectable Stage II-IV Head and Neck Cutaneous Squamous Cell Cancer Before Surgery [Phase 2]

  A Phase 2 clinical trial evaluating cemiplimab given before surgery in patients with recurrent and resectable stage II-IV head and neck cuta…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.